DNA Encoded Library Market Revenue to Cross over $5 billion by 2035 | Roots Analysis

According to a recently published report by Roots Analysis, given the benefits offered by DNA encoded library, including high diversity, minimal false positives, stability, rapid screening and reduced costs, the use of DNA encoded libraries has increased over the past few years

DNA Encoded Library Industry Overview

The global DNA encoded library market is anticipated to grow at a CAGR of 16.04% from 2023-2035, reaching USD 5 billion by 2035.

DNA encoded libraries are a powerful molecular screening tool, which leverages the unique information storage capability of DNA to construct extremely large molecular repositories that can be used for high throughput screening experiments. Using traditional high throughput screening methods scientists are able to interrogate large libraries of a couple million compounds, one by one, in order to identify potential pharmacological leads. However, this is a time and cost intensive process, requiring capital investments in the order of billions of dollars and elaborate instrumentation and infrastructure for library generation, storage and screening experiments. In sharp contrast, a DNA encoded library can be synthesized to include billions, or even trillions, of potential molecular leads and be made to fit into a space the size of an Eppendorf snap-cap tube. Further, the creation of such elaborate information repositories is comparatively less expensive; experts suggest that the cost of construction and experimental use of such libraries may range between tens to hundreds of thousands of dollars. The cost saving potential of DNA encoded libraries is attributed to the fact that such libraries are synthesized, stored and used as a single mixture.

To order this 280+ page report, which features 135+ figures and 145+ tables, please visit https://www.rootsanalysis.com/reports/dna-encoded-libraries/288.html

Market Drivers

Several factors are propelling the growth of the DNA encoded library market. The identification of suitable molecules that are capable of binding to specific biological targets and mediating a therapeutic effect is the primary challenge in the field of chemistry, biology and medicine. As a result, many research groups are engaged in exploring technologies that can efficiently facilitate the identification of ligands for drug discovery. DNA encoded libraries represent one of the latest and most versatile methods of molecular screening, which enables high throughput screening of large libraries of compounds in an inexpensive and timebound manner. Functioning analogous to the phage display technique, which is used for antibody development, this method of hit-generation and screening has revolutionized the small molecule drug discovery.  The increasing demand for effective methods to screen potential drug targets has fueled a rise in interest in DNA encoded libraries, further supported by technological advancements.

Market Restraints

While the DNA encoded library market is experiencing substantial growth, it is not without its challenges. Despite having numerous advantages, DNA encoded libraries are fraught with various challenges. Although DNA encoded libraries have been successful in enabling the identification and isolation of hits against several types of target proteins, certain studies have reported their inability to be used to interrogate certain protein classes. Therefore, even though these libraries have gradually been accepted into mainstream drug discovery applications, there is still scope for further improvement. In this context, researchers engaged in this field are also anticipating advances in DNA sequencing technologies that will further increase the number of DNA tags that can be sequenced at a time.

Growth Factors

Despite the challenges, several growth factors continue to drive the DNA encoded library market forward. One notable factor is the use of DNA encoded library technology during the early stages of drug discovery since it requires less investment, time and storage space to identify target compounds. Additionally, the DNA encoded library market is currently abuzz with activity; industry players have forged several strategic alliances and received significant financial support from investors. This can be attributed to the various benefits offered by these platforms, such as cost effectiveness, high diversity, minimal false positives, stability and rapid hit identification.

DNA Encoded Library Market Segments

Based on application areas, the DNA encoded library market is segmented into hit generation / identification, hit to lead, hit validation / optimization and other application areas.

• By 2035, majority of the revenue share (60%) of the overall DNA encoded library market is likely to be driven by hit generation / identification. This trend is unlikely to change in the foreseen future as well. This can be attributed to the wide use of DNA encoded libraries in hit generation and identification.
• Further, the market for hit to lead applications, is anticipated to grow at a relatively faster pace (CAGR of 15.9%), owing to the increasing interest of stakeholders in using DNA encoded libraries for hit to lead processes.

Based on therapeutic areas, the DNA encoded library market is segmented into oncological disorders, immunological disorders, neurological disorders, respiratory disorders, dermatological disorders, cardiovascular disorders, infectious diseases and other therapeutic areas.

• Oncological disorders currently hold the largest share (35%) of the market. This trend is primarily driven by the significant rise in drug discovery initiatives focused on oncological indications, worldwide.
• This growing interest indicates the potential of DNA encoded libraries in discovering effective hits against cancer indications.

Based on the end-user, the DNA encoded library market is segmented into pharma / biopharma industry, academic / research institute and other end-users.

• The pharma / biopharma industry holds the largest market share, accounting for 67% of the overall DNA encoded library market in 2023.
• This can be attributed to fact that pharma / biopharma industry is utilizing DNA encoded library platforms for small molecule drug discovery purposes and to address the current unmet therapeutic needs. These pharma / biopharma companies leverage DNA encoded libraries to efficiently discover pharmaceutical leads against specific disease targets, facilitating the drug discovery and development process.

Based on the type of payment method, the DNA encoded library market is segmented into upfront payment and milestone payment.

• Milestone payments currently captures the maximum share in the overall DNA encoded library market and this trend is unlikely to change during the forecast period.
• Further, the ongoing efforts in the pharmaceutical domain are likely to translate into great opportunities for companies offering DNA encoded libraries; these libraries can be used to discover pharmaceutical leads for undruggable targets against different disease segments, in a time and cost-effective manner.

Based on the Regional Insights, the DNA encoded library market is segmented into North America (US), Europe (UK, Germany, Denmark, France, Switzerland and Rest of the Europe), and Asia-Pacific (China)

• North America and Europe dominated the DNA encoded library market and accounted for the largest revenue share of about 70% by 2035.
• In Asia Pacific, the market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The DNA encoded library market report also includes detailed profiles of key players (listed below) that offer DNA encoded library platforms and services:

• AlphaMa 
• DICE Therapeutics
• DyNAbind
• HitGen
• NovAliX
• Vipergen
• WuXi AppTec
• X-Chem

You Can Download Free Sample PDF Copy Of This Report At:
https://www.rootsanalysis.com/reports/dna-encoded-libraries/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com